Related Experiment Video
Updated: Sep 14, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
Optimizing Timing for Respiratory Syncytial Virus Prevention Interventions for Infants
Danielle Nguyen1, Haeseon Lee1, Andrew T Pavia2
1Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City.
Maternal vaccine (MV) and nirsevimab are recommended for infant respiratory syncytial virus (RSV) protection. MV is cost-effective for RSV prevention in infants born early in the season, while nirsevimab is cost-effective only for the earliest months.
Area of Science:
- Public Health
- Health Economics
- Pediatrics
Background:
- The Centers for Disease Control and Prevention recommend maternal vaccine (MV) or nirsevimab for infant protection against respiratory syncytial virus (RSV).
- The cost-effectiveness of these interventions may vary based on administration timing, uptake, and efficacy.
Purpose of the Study:
- To evaluate the clinical outcomes and cost-effectiveness of maternal vaccine (MV) and nirsevimab for infant RSV prevention.
- To compare these interventions against no intervention for monthly birth cohorts and the entire RSV season.
Main Methods:
- Economic evaluation using a Markov model from a societal perspective.
- Analysis incorporated a willingness-to-pay threshold of $150,000 per QALY.
- Included infants born in the US during the RSV season (October-February).
Main Results:
- Maternal vaccine (MV) was cost-saving for infants born in October, November, and December, and cost-effective for the combined October-February cohort ($19,562/QALY).
- Nirsevimab was cost-effective compared to MV only for infants born in October ($67,178/QALY) and November ($88,531/QALY).
- MV was projected to avert 7,154 hospitalizations and 12 deaths; nirsevimab was projected to avert 11,893 hospitalizations and 19 deaths during the RSV season.
Conclusions:
- Administering maternal vaccine (MV) during the first four months and throughout the RSV season can be cost-effective.
- Nirsevimab demonstrated cost-effectiveness compared to MV only for infants born in October and November.
- Optimizing intervention use by restricting administration to specific months may be beneficial; further research on transmission dynamics is needed.
More Related Videos
Related Concept Videos
Assessment of Ventilation I: Respiratory Rate
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...

